Skip to main content
. 2001 Jan;45(1):252–262. doi: 10.1128/AAC.45.1.252-262.2001

FIG. 5.

FIG. 5

Mean (±SEM) NO levels in lung homogenates (A) and BALF (B) of infected and healthy mice, treated or not with HMR 3004 at 25 mg/kg/day. A significant prevention in NO release was noted in infected treated mice in comparison to untreated infected mice. Therapy was initiated 48 h p.i. ∗, P < 0.05.